Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1

被引：46

作者：

Blatter-Garin, MC ^{[1
]}

Kalix, B ^{[1
]}

De Pree, S ^{[1
]}

James, RW ^{[1
]}

机构：

[1] Univ Hosp Geneva, Dept Endocrinol & Diabet, Clin Diabet Unit, Geneva, Switzerland

来源：

DIABETOLOGIA | 2003年 / 46卷 / 04期

关键词：

D O I：

10.1007/s00125-003-1065-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：593 / 594

页数：2

共 8 条

[1] SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].

ABBOTT, CA ;

MACKNESS, MI ;

KUMAR, S ;

BOULTON, AJ ;

DURRINGTON, PN .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818

[2] Aspirin [J].

Awtry, EH ;

Loscalzo, J .

CIRCULATION, 2000, 101 (10) :1206-1218

[3] LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects [J].

Barbieri, M ;

Bonafè, M ;

Marfella, R ;

Ragno, E ;

Giugliano, D ;

Franceschi, C ;

Paolisso, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :222-225

[4] Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation [J].

Boemi, M ;

Leviev, I ;

Sirolla, C ;

Pieri, C ;

Marra, M ;

James, RW .

ATHEROSCLEROSIS, 2001, 155 (01) :229-235

[5] Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families [J].

Deakin, S ;

Leviev, I ;

Nicaud, V ;

Meynet, MCB ;

Tiret, L ;

James, RW .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1268-1273

[6] The hunt for nutritional and pharmacological modulators of paraoxonase [J].

Durrington, PN ;

Mackness, B ;

Mackness, MI .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) :1248-1250

[7] Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease [J].

James, RW ;

Leviev, I ;

Righetti, A .

CIRCULATION, 2000, 101 (19) :2252-2257

[8] Paraoxonase and coronary heart disease [J].

Mackness, MI ;

Mackness, B ;

Durrington, PN ;

Fogelman, AM ;

Berliner, J ;

Lusis, AJ ;

Navab, M ;

Shih, D ;

Fonarow, GC .

CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (04) :319-324

← 1 →